PEAR Past Earnings image   This PEAR past earnings page last updated 9/28/2022
PEAR Past Earnings
PeriodPast Earnings DateGAAP
Q2 20228/11/20220.040
Q1 20225/16/2022-0.170
Q4 20213/28/2022-0.240
PEAR Past Revenue
PeriodPast Earnings DateGAAP
Q2 20228/11/20220.00B
Q1 20225/16/20220.00B
Q4 20213/28/20220.00B
Quotes delayed 20 minutes

Email EnvelopeFree PEAR Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Pear Therapeutics (PEAR) is categorized under the Miscellaneous sector; to help you further research past earnings across stocks, below are some other companies in the same sector:

PL Past Earnings
PNT Past Earnings
PRSO Past Earnings
PSFE Past Earnings
PWP Past Earnings
QSI Past Earnings
RBOT Past Earnings
RDBX Past Earnings
RDW Past Earnings
RIOT Past Earnings

PEAR Past Earnings Q&A

What was the best and worst PEAR past earnings results?
For Pear Therapeutics, I'm wondering what the company's very best and worst earnings results have been, on an earnings per share basis?

✔️Accepted answer: The highest PEAR past earnings result in our data set was 0.040/share posted in Q2 2022, while the lowest was in Q4 2021 when PEAR posted -0.240/share.

  Suggested answer: The biggest top line earnings performance — aka revenue — quarter was in Q2 2022 when PEAR reported 0.00B in revenue, while the quarter with the lowest revenue in our data set was Q4 2021 at 0.00B of revenue.

  Suggested answer: There are 3 PEAR past earnings results in our data set.

On this page we presented the PEAR past earnings date information for Pear Therapeutics. Reviewing that PEAR Past Earnings for the company, we see that the highest past earnings result in our data set was in Q2 2022, when PEAR posted gaap of 0.040/share. Meanwhile the lowest PEAR past earnings result was in Q4 2021, when PEAR posted gaap of -0.240/share. Turning to top line revenue performance, the biggest revenue quarter in our data set was seen in Q2 2022 when PEAR reported 0.00B in revenue, while the smallest revenue quarter was Q4 2021 when PEAR reported 0.00B in revenue.

Any self directed investor doing their due diligence on PEAR or any other given stock can benefit from researching all of the Pear Therapeutics past earnings — and here, we present each quarter's result all together on one page for easy comparison. Studying this information can help when projecting future earnings, as well as determining whether the past earnings trajectory justifies the current stock value. That's why we bring you PastEarnings.com to make it easy for investors to investigate Pear Therapeutics past earnings, or the past earnings information for any stock in our coverage universe. And in your continued research we hope you will be sure to check out the further links included for earnings surprises history (beat/miss data) as well as next earnings dates for PEAR. Thanks for visiting, and the next time you need to research PEAR past earnings or those of another stock, we hope you'll think of our site, as your go-to past earnings research resource of choice.

Recommended: VERU Average Annual Return, CORI Options Chain, WAVX Options Chain.

 

PEAR Past Earnings | www.PastEarnings.com | Copyright © 2020 - 2022, All Rights Reserved

Nothing in PastEarnings.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.